S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

DNLI Denali Therapeutics Inc

16.81

0.65 (4.02%)

After Hours

Last Updated: 15:02:46

Delayed by 15 minutes

Denali Therapeutics reports positive DNL310 data in mid-stage hunter syndrome study

To read the full story on Seeking Alpha, click here.

Denali Therapeutics (NASDAQ:DNLI)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Denali Therapeutics Charts.

Denali Therapeutics (NASDAQ:DNLI)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Denali Therapeutics Charts.

Denali Therapeutics Inc News

Denali Therapeutics Announces Completion of Enrollment for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial
Wednesday 1 May 2024 (1 day ago) • GlobeNewswire Inc.

Form D - Notice of Exempt Offering of Securities
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)

Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Tuesday 27 February 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)

Denali Therapeutics Announces $500 million Private Placement Equity Financing
Tuesday 27 February 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 16 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 14 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 14 February 2024 (3 months ago) • Edgar (US Regulatory)

More Denali Therapeutics Inc News Articles

BlackStar Enterprise (PK)

Globestar Therapeutics (PK)

Atacama Resources (PK)

Therapeutic Solutions (PK)

Voip Pal Com (QB)

International Star (PK)

MicroCloud Hologram

Mullen Automotive

Verb Technology

FBEC Worldwide (PK)

Buildablock (PK)

Brookmount Explorations (PK)

Anavex Life Sciences

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions